WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

ANTI INFLAMMATORY EFFECT OF ALOGLIPTIN IN ISCHAEMIAREPERFUSION INDUCED CEREBRAL INFARCTION IN NORMAL AND STZ INDUCED TYPE-II DIABETIC RATS

K. Purnachander*, K. P. R. Chowdary and N. Kannappan

ABSTRACT

Type 2 Diabetes mellitus is an important risk factor for cerebral ischemic stroke. Oxidative stress in Type 2 Diabetes Mellitus causes irreversible neuronal damage during cerebral ischemic stroke. Free radicals cause oxidative stress and inflammation leading to increased injury in cerebral ischemia. Inflammation is the main culprit in cerebral ischemia/reperfusion injury. Alogliptin is the newer antidiabetic drug (DPP-4 inhibitor) is reported to have antiinflammatory action. The aim of the present study is to evaluate the antineuroinflammatory effect of Alogliptin against cerebral ischemia/reperfusion injury in normal and STZ induced diabetic rats. Bilateral common carotid artery occlusion (BCCAO) followed by 4 h reperfusion is the animal model used in the present study. Treatment with Alogliptin 30 mg/kg for a period of four weeks showed significant reduction in percent cerebral infarct volume. Alogliptin at 30 mg/kg dose also showed significant reduction in biomarkers like Myeloperoxidase, Tumor Necrosis Factor-α, Interleukin-6 (IL-6)and Interleukin-1β(IL-1β) in diabetic group when compared to normal group. Significant increase in IL-10 levels were observed in diabetic group when compared to normal group.

Keywords: cerebral ischemia/reperfusion injury, T2DM, Inflammation, Alogliptin.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More